Otten BJ - Search Results

1

Effects of growth hormone treatment on left ventricular dimensions in children with Noonan's syndrome.

Noordam C, Draaisma JM, van den Nieuwenhof J, van der Burgt I, Otten BJ, Daniels O. Noordam C, et al. Among authors: otten bj. Horm Res. 2001;56(3-4):110-3. doi: 10.1159/000048101. Horm Res. 2001. PMID: 11847472 Clinical Trial.

2

Genetics and variation in phenotype in Noonan syndrome.

Jongmans M, Otten B, Noordam K, van der Burgt I. Jongmans M, et al. Horm Res. 2004;62 Suppl 3:56-9. doi: 10.1159/000080500. Horm Res. 2004. PMID: 15539800

3

Growth hormone (GH) secretion in children with Noonan syndrome: frequently abnormal without consequences for growth or response to GH treatment.

Noordam C, van der Burgt I, Sweep CG, Delemarre-van de Waal HA, Sengers RC, Otten BJ. Noordam C, et al. Among authors: otten bj. Clin Endocrinol (Oxf). 2001 Jan;54(1):53-9. doi: 10.1046/j.1365-2265.2001.01188.x. Clin Endocrinol (Oxf). 2001. PMID: 11167926

4

Growth hormone treatment in children with Noonan's syndrome: four year results of a partly controlled trial.

Noordam C, Van der Burgt I, Sengers RC, Delemarre-van de Waal HA, Otten BJ. Noordam C, et al. Among authors: otten bj. Acta Paediatr. 2001 Aug;90(8):889-94. Acta Paediatr. 2001. PMID: 11529537 Clinical Trial.

5

Bone mineral density and body composition in Noonan's syndrome: effects of growth hormone treatment.

Noordam C, Span J, van Rijn RR, Gomes-Jardin E, van Kuijk C, Otten BJ. Noordam C, et al. Among authors: otten bj. J Pediatr Endocrinol Metab. 2002 Jan;15(1):81-7. doi: 10.1515/jpem.2002.15.1.81. J Pediatr Endocrinol Metab. 2002. PMID: 11826869 Clinical Trial.

6

Growth hormone treatment in cartilage-hair hypoplasia: effects on growth and the immune system.

Bocca G, Weemaes CM, van der Burgt I, Otten BJ. Bocca G, et al. Among authors: otten bj. J Pediatr Endocrinol Metab. 2004 Jan;17(1):47-54. doi: 10.1515/jpem.2004.17.1.47. J Pediatr Endocrinol Metab. 2004. PMID: 14960021 Clinical Trial.

7

Response to growth hormone treatment and final height in Noonan syndrome in a large cohort of patients in the KIGS database.

Raaijmakers R, Noordam C, Karagiannis G, Gregory JW, Hertel NT, Sipilä I, Otten BJ. Raaijmakers R, et al. Among authors: otten bj. J Pediatr Endocrinol Metab. 2008 Mar;21(3):267-73. doi: 10.1515/jpem.2008.21.3.267. J Pediatr Endocrinol Metab. 2008. PMID: 18540254 Free article.

8

Long-term GH treatment improves adult height in children with Noonan syndrome with and without mutations in protein tyrosine phosphatase, non-receptor-type 11.

Noordam C, Peer PG, Francois I, De Schepper J, van den Burgt I, Otten BJ. Noordam C, et al. Among authors: otten bj. Eur J Endocrinol. 2008 Sep;159(3):203-8. doi: 10.1530/EJE-08-0413. Epub 2008 Jun 18. Eur J Endocrinol. 2008. PMID: 18562489 Clinical Trial.

9

Growth in Noonan syndrome.

Otten BJ, Noordam C. Otten BJ, et al. Horm Res. 2009 Dec;72 Suppl 2:31-5. doi: 10.1159/000243776. Epub 2009 Dec 22. Horm Res. 2009. PMID: 20029234

10

The relationship between clinical severity of Noonan's syndrome and growth, growth hormone (GH) secretion and response to GH treatment.

Noordam K, van der Burgt I, Brunner HG, Otten BJ. Noordam K, et al. Among authors: otten bj. J Pediatr Endocrinol Metab. 2002 Feb;15(2):175-80. doi: 10.1515/jpem.2002.15.2.175. J Pediatr Endocrinol Metab. 2002. PMID: 11874182

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

168 results

Search Page

Filters